UnitedHealth Stock News

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (^DJI 0.78%) had just a 12.9% return, compared to 23.3% for the S&P 500 (^GSPC 1.00%) and 28.6% for the Nasdaq Composite.

UNH has been sold off, thanks to the market's overreaction to the FQ4'24 top-line miss and mixed FY2025 guidance, as medical costs continue to grow. Despite headwinds, robust growth in Optum Rx and OptumHealth segments may balance UnitedHealthcare challenges, supporting the management's ambitious FY2025 targets. The consensus downgrades and UNH's discounted valuations highlight the market's pes...

Here are some of the major companies whose stocks moved on the week's news.

UnitedHealth Group (NYSE: UNH) recently reported its Q4 results, with revenues missing and earnings exceeding the street expectations. The company reported revenue of $100.8 billion and adjusted earnings of $6.81 per share, compared to the consensus estimates of $101.8 billion and $6.72, respectively.

UnitedHealth Group (UNH) shares fell sharply Thursday after the health insurer reported fourth-quarter results below Wall Street's expectations and issued a lackluster outlook amid higher medical costs.

Major U.S. equities indexes ticked lower on Thursday, failing to gain ground a day after soft inflation data and an upbeat start to earnings season helped drive a strong rally.

Digital transformation is at the forefront of an overarching strategy to elevate the customer experience for officials at UnitedHealth Group.

Shares of UnitedHealth Group (UNH -4.86%) were pulling back Thursday after the company delivered underwhelming fourth-quarter results, as sales were weaker than expected and its costs rose.